R&D Systems™ Recombinant Human IFN-alpha A Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IFN-alpha A Protein is derived from E. coli. The Recombinant Human IFN-alpha A Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: V00549
• For Use With (Application): Bioactivity
• Formulation: Phosphate buffered saline (PBS)
• Molecular Weight (g/mol): Predicted MW: 19.2kDa
• Name: IFN-alpha 2
• Purification Method: A combination of ion exchange, hydrophobic interaction and size exclusion chromatography
• Quantity: 5 μg
• Source: E. coli-derived human IFN-alpha A protein
• Storage Requirements: Store the unopened product at -20 to -70° C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• Gene Alias: alpha-2a interferon, Ifa2, IFNA, IFNA2, IFNA2a, IFNA2b, IFNA2c, IFNAA, IFNalpha 2, IFN-alpha-2, IFN-alphaA, INFA2, interferon alpha 2b, interferon alpha A, interferon alpha-2, Interferon alpha-A, interferon, alpha 2, LeIF A, MGC125764, MGC125765
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >95%